TABLE 2.

Main^# clinical characteristics and outcome of transplanted COVID-19 acute respiratory distress syndrome patients (n=19)

Patient	Age (years)	Gender	Length of MV until LTx (days)	Length of ECMO support until LTx (days)	Type of LTx	Post-operative ECMO prolongation	Length of ICU stay (days)	Discharged from hospital	Follow-up (days)	Alive/dead (cause of death)
1	44	Female	52	45	Bilateral, no size reduction	Yes	63	Yes	450	Alive
2	55	Male	29	23	Bilateral, no size reduction	No	55	Yes	300	Alive
3	54	Male	55	47	Trilobar¶	Yes	98	No	147	Dead (subdural haematoma)
4	57	Male	57	46	Bilateral, size-reduced+	No	80	No	154	Dead (liver failure)
5	61	Male	50	43	Bilateral, size-reduced+	No	Not reached	No	66	Dead (liver failure)
6	54	Male	39	27	Bilateral, no size reduction	No	37	Yes	207	Alive
7	49	Male	41	41	Bilateral, no size reduction	No	12	Yes	189	Alive
8	64	Male	28	17	Bilateral, no size reduction	Yes	32	Yes	180	Alive
9	56	Male	30	2	Bilateral, no size reduction	No	27	Yes	162	Alive
10	46	Female	52	52	Bilateral, no size reduction	Yes	90	No	154	Alive
11	64	Male	60	23	Bilateral, no size reduction	No	Not reached	No	111	Dead (multi-organ failure)
12	58	Male	50	8	Bilateral, no size reduction	No	25	Yes	133	Alive
13	34	Female	46	45	Bilateral, size-reduced+	No	25	Yes	115	Alive
14	61	Male	51	43	Bilateral, size-reduced+	Yes	27	No	105	Alive
15	56	Male	38	29	Bilateral, no size reduction	No	37	Yes	93	Alive
16	53	Male	76	66	Bilateral, no size reduction	Yes	Still admitted§	No	85	Alive
17	47	Male	38	36	Bilateral, no size reduction	No	34	No	65	Dead (liver failure)
18	62	Male	47	34	Bilateral, size-reduced+	No	30	No	69	Alive
19	57	Male	82	59	Bilateral, no size reduction	No	Still admitted§	No	47	Alive

MV: mechanical ventilation; ECMO: extracorporeal membrane oxygenation; LTx: lung transplantation; ICU: intensive care unit. ^#: more details are provided in supplementary table S2; ^¶: right upper, right lower and left upper lobe; ⁺: without middle lobe and lingula; ^§: as of 11 August 2021.